Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP5 Unlocking Potential: Fenbendazole's Emerging Role in Cancer Therapy.
Fenben® Voices
4 minutes
1 year ago
S1EP5 Unlocking Potential: Fenbendazole's Emerging Role in Cancer Therapy.
Got Questions? Send us a message!Podcast Episode Description:Dive into "Unlocking Potential: Fenbendazole's Emerging Role in Cancer Therapy" on "Fenben Voices," where we uncover the promising anti-tumor effects of Fenbendazole (FBZ), traditionally a veterinary medicine. This episode explores:The intriguing shift towards FBZ in cancer treatment.Highlights from a case series study by Stanford University Medical Center.The need for further research to solidify FBZ's place in human oncology.Join ...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
